FindMyKOL

Nalini Guda, MD

Basic profile

Aurora St. Luke's Medical Center

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionMilwaukee, WI · MidwestSpecialtyGastroenterologyFocusGastroenterology
Active KOLFindMyKOL type: NationalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nalini Guda is a Gastroenterology physician affiliated with Aurora St. Luke's Medical Center. OpenAlex indexes 225 publications with 4,673 citations (h-index 33); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
225publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

4,673citations

Citations across these publications.

33h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Olympus America Inc.
    Program year20255 payments
    $10,178
  • Medtronic, Inc.
    Program year20251 payment
    $1,250
  • Cook Medical LLC
    Program year20254 payments
    $370
All 21 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    83.1%
    Proton pump inhibitor43.9%
    Omeprazole47%Pantoprazole Sodium45%Esomeprazole Magnesium8%
    Part D≥70 patients
    Osmotic Laxative13.7%
    Gavilyte-G88%Peg-3350 And Electrolytes12%
    Part D≥106 patients

    + 6 more classes in this area

  • Nervous system

    6.7%
    Cholinesterase Inhibitor3.7%
    Pyridostigmine Bromide100%
    Part D≥11 patients
    Tricyclic Antidepressant3%
    Amitriptyline Hcl100%
    Part D<11 patients
  • Cancer & immunology

    5.6%
    Purine Antimetabolite3.5%
    Azathioprine100%
    Part D<11 patients
    TNF inhibitor2%
    Humira(Cf) Pen100%
    Part D<11 patients
Where care is delivered (Part B)82.4% facility · 17.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”